{
    "title": "S.Africa's Aspen to sell U.S. drug rights to Mylan for up to $300 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2750904/S-Africas-Aspen-sell-U-S-drug-rights-Mylan-300-mln.html",
    "date": "2014-09-10",
    "keywords": [
        "year",
        "drug",
        "gmt",
        "market",
        "rand",
        "september",
        "inc",
        "wednesday",
        "sale",
        "part",
        "percent",
        "rise",
        "plant",
        "debt",
        "companys",
        "share",
        "home",
        "profit",
        "safricas",
        "email",
        "tiisetso",
        "motsoenengjohannesburg",
        "pharmacare",
        "blood",
        "clot",
        "mylan",
        "move",
        "drugmaker",
        "debtmylan",
        "rest",
        "party",
        "payment",
        "thrombosis",
        "lack",
        "representation",
        "wider",
        "review",
        "portfolio",
        "executive",
        "gus",
        "attridge",
        "aspen",
        "fall",
        "bluechip",
        "jse",
        "top40",
        "indexaspen",
        "growth",
        "glaxosmithkline",
        "push",
        "marketslast",
        "merck",
        "co",
        "nutrition",
        "mexicobut",
        "spending",
        "ratio",
        "target",
        "timesattridge",
        "cash",
        "flow",
        "marketing",
        "debttoebitda",
        "multiple",
        "june",
        "consensus",
        "estimate",
        "poll",
        "measure",
        "business",
        "flat",
        "revenue",
        "europe",
        "rival",
        "adcock",
        "ingram",
        "loss",
        "month",
        "currency",
        "price",
        "economy",
        "consumer",
        "spending1",
        "dollar",
        "rediting",
        "stella",
        "mapenzauswa",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}